Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. Company
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Roche Holding AG
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Number of employees : 101 465 people.
Sales per Business
20192020Delta
Pharmaceuticals50 714.0082.5%46 491.0079.7% -8.33%
Diagnostics13 037.0021.2%13 852.0023.8% +6.25%
CHF in Million
Sales per region
20192020Delta
United States31 164.0050.7%28 630.0049.1% -8.13%
Rest of Europe9 672.0015.7%9 785.0016.8% +1.17%
Rest of Asia8 717.0014.2%8 627.0014.8% -1.03%
Japan4 674.007.6%4 254.007.3% -8.99%
Germany3 084.005%3 352.005.7% +8.69%
Latin America2 858.004.6%2 393.004.1% -16.27%
Africa, Australia and Oceania1 359.002.2%1 318.002.3% -3.02%
Switzerland1 237.002%1 101.001.9% -10.99%
Rest of North America986.001.6%883.001.5% -10.45%
CHF in Million
Managers
Name Title Age Since
Severin Schwan Chief Executive Officer & Executive Director 53 2015
Alan Hippe Chief Financial & Information Technology Officer 69 2011
Urs Jaisli Chief Compliance Officer 64 2015
André S. Hoffmann Vice Chairman 62 2012
Christoph Franz Chairman 61 2014
Karl Mahler, Dr. Head-Investor Relations - 2010
Gottlieb A. Keller, Dr. Secretary & General Counsel 66 -
Michael D. Varney, Dr. Head-Genentech Research & Early Development 61 2015
William Pao, Dr. Head-Pharma Research & Early Development 53 2018
Per-Olof Attinger Secretary-Executive Committee & Head-CEO Office 60 2010
Members of the board
Name Title Age Since
Christoph Franz Chairman 61 2014
Paul Bulcke Non-Executive Director 66 2012
André S. Hoffmann Vice Chairman 62 2012
Severin Schwan Chief Executive Officer & Executive Director 53 2015
Bernard J. Poussot Non-Executive Director 68 2015
Richard P. Lifton, Dr. Non-Executive Director 67 2015
Claudia Süssmuth Dyckerhoff, Dr. Director 53 2016
Julie Brown Director 58 2016
Anita Hauser Director 51 2017
Hans Clevers, Dr. Director 62 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 702,562,700 694,260,903 98.8% 8,301,797 1.2% 83.5%
Stock B 1 160,000,000 26,325,039 16.5% 0 0.0%
Shareholders
NameEquities%
Norges Bank Investment Management 19,938,101 2.84%
The Vanguard Group, Inc. 19,078,824 2.72%
Fidelity Management & Research Co. LLC 12,076,955 1.72%
UBS Asset Management Switzerland AG 11,729,685 1.67%
BlackRock Fund Advisors 11,663,163 1.66%
Roche Holding AG 9,436,750 1.34%
Credit Suisse Asset Management (Schweiz) AG 8,805,944 1.25%
Massachusetts Financial Services Co. 7,636,070 1.09%
Zürcher Kantonalbank (Investment Management) 6,929,163 0.99%
Flossbach von Storch AG 6,548,800 0.93%
Holdings
NameEquities%Valuation
CHUGAI PHARMACEUTICAL CO., LTD. (4519) 1,005,670,000 59.9% 37,457,406,067 USD
ROCHE HOLDING AG (RO) 53,323,899 33.3% 22,934,382,867 USD
ROCHE HOLDING AG (ROG) 9,436,750 1.34% 3,656,450,067 USD
SENSEONICS HOLDINGS, INC. (SENS) 35,046,418 7.87% 122,662,463 USD
VAXCYTE, INC. (PCVX) 2,587,754 4.96% 60,553,444 USD
ALIGOS THERAPEUTICS, INC. (ALGS) 3,092,340 7.26% 49,260,976 USD
JASPER THERAPEUTICS, INC. (JSPR) 4,624,606 12.7% 42,222,653 USD
ELOXX PHARMACEUTICALS, INC. (ELOX) 2,532,270 2.94% 3,469,210 USD
TEMPEST THERAPEUTICS, INC. (TPST) 72,612 1.08% 851,013 USD
Company contact information
Roche Holding AG
Grenzacherstrasse 124
Basel, Basel-Stadt (Basle Town) 4070

Phone : +41.61.688.11.11
Fax : +41.61.691.93.91
Web : http://www.roche.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Roche Holding AG
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ROCHE HOLDING AG16.05%336 162
JOHNSON & JOHNSON1.82%419 109
PFIZER, INC.46.70%303 095
NOVO NORDISK A/S67.00%247 254
ELI LILLY AND COMPANY54.21%236 049
ABBVIE INC.8.74%205 976
MERCK & CO., INC.-3.23%199 954
NOVARTIS AG-10.68%181 102
ASTRAZENECA PLC14.84%173 523
BRISTOL-MYERS SQUIBB COMPANY-8.42%125 477
SANOFI8.02%120 755
AMGEN INC.-12.54%113 267
GLAXOSMITHKLINE PLC12.58%100 759
CHUGAI PHARMACEUTICAL CO., LTD.-28.68%56 933
JIANGSU HENGRUI MEDICINE CO., LTD.-43.64%52 191
BAYER AG-5.43%50 628
DAIICHI SANKYO COMPANY, LIMITED-16.78%49 746
TAKEDA PHARMACEUTICAL COMPANY LIMITED-16.48%43 512
ASTELLAS PHARMA INC.18.73%30 934
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY42.86%23 703
CATALENT, INC.27.14%22 650